Literature DB >> 10467430

Insulin-like growth factor binding proteins and their functions (minireview).

Y Kostecka1, J Blahovec.   

Abstract

Insulin-like growth factor (IGF) action is influenced by the insulin-like growth factor binding proteins (IGFBPs). Since 1988 eight forms of IGFBPs have been found which differ in molecular weight, amino acid composition, distribution in biological fluids and influence upon IGF activity. An important biological property of the IGFBPs is their ability to increase the halflife of the IGFs in the blood. They are able to act as potentiators of IGFs activity on the cell proliferation. As IGFBPs bind to cell surfaces, they may act either to deliver the IGFs to those surfaces either for the activation of specific receptors or cell responses independently of receptor activation. Posttranslation modification such as phosphorylation, glycosylation and proteolysis of IGFBPs influence their affinity to IGFs. In addition, the IGFBPs may also act as inhibitors to block the activity of the IGFs by preventing cellsurface binding.

Mesh:

Substances:

Year:  1999        PMID: 10467430

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  7 in total

Review 1.  The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge.

Authors:  Rajaraman Durai; Wenxuan Yang; Sharmila Gupta; Alexander M Seifalian; Marc C Winslet
Journal:  Int J Colorectal Dis       Date:  2005-01-14       Impact factor: 2.571

2.  Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study.

Authors:  Lorelei A Mucci; Jennifer R Stark; Michael N Pollak; Haojie Li; Tobias Kurth; Meir J Stampfer; Jing Ma
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

3.  Screening and Functional Pathway Analysis of Pulmonary Genes Associated with Suppression of Allergic Airway Inflammation by Adipose Stem Cell-Derived Extracellular Vesicles.

Authors:  Sung-Dong Kim; Shin Ae Kang; Yong-Wan Kim; Hak Sun Yu; Kyu-Sup Cho; Hwan-Jung Roh
Journal:  Stem Cells Int       Date:  2020-06-27       Impact factor: 5.443

4.  Comparison and validation of ELISA assays for plasma insulin-like growth factor-1 in the horse.

Authors:  Courtnay L Baskerville; Nicholas J Bamford; Patricia A Harris; Simon R Bailey
Journal:  Open Vet J       Date:  2017-03-31

5.  Expression of various insulin-like growth factor-1 mRNA isoforms in colorectal cancer.

Authors:  Aldona Kasprzak; Witold Szaflarski; Jacek Szmeja; Małgorzata Andrzejewska; Wiesława Przybyszewska; Maria Koczorowska; Michał Drews; Elżbieta Kaczmarek
Journal:  Contemp Oncol (Pozn)       Date:  2012-05-29

6.  The effect of acclydine in chronic fatigue syndrome: a randomized controlled trial.

Authors:  Gerard K H The; Gijs Bleijenberg; Jos W M van der Meer
Journal:  PLoS Clin Trials       Date:  2007-05-18

Review 7.  Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma.

Authors:  Reham Abdel-Wahab; Samir Shehata; Manal M Hassan; Mouhammed A Habra; Ghazaleh Eskandari; Peggy T Tinkey; Jennifer Mitchell; Ju-Seog Lee; Hesham M Amin; Ahmed O Kaseb
Journal:  J Hepatocell Carcinoma       Date:  2015-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.